PAR PHARMACEUTICAL COMPANIES, INC. Repayments of Long-Term Debt
PAR PHARMACEUTICAL COMPANIES, INC. reported Repayments of Long-Term Debt of $9.38 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2015-08-06
- PAR PHARMACEUTICAL COMPANIES, INC. repayments of long-term debt for the quarter ending 2015-06-30 was $4.69M.
- PAR PHARMACEUTICAL COMPANIES, INC. repayments of long-term debt for the quarter ending 2015-03-31 was $4.69M, a 96.66% decline year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. repayments of long-term debt for the quarter ending 2014-09-30 was $2.21M, a 16.89% decline year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. repayments of long-term debt for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month |
|---|---|---|---|
| 2015-06-30 | $4.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $9.38M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $4.69M 10-Q · filed 2015-05-11 | ||
| 2014-09-30 | $2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $2.21M derived: sum of 2 quarters · filed 2015-08-06 | $142.41M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $140.19M 10-Q · filed 2015-08-06 | |
| 2014-03-31 | $140.19M 10-Q · filed 2015-05-11 | ||
| 2013-09-30 | $2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $60.33M derived: sum of 2 quarters · filed 2014-11-12 | $204.22M 10-Q · filed 2014-11-12 |
| 2013-06-30 | $57.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $201.55M 10-Q · filed 2014-08-11 | |
| 2013-03-31 | $143.89M 10-Q · filed 2014-05-15 |